Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia. (4th May 2022) - Jamy, Omer; Lin, Karen; Worth, Sarah; Bachiashvili, Kimo; Rangaraju, Sravanti; Vachhani, Pankit; Bhatia, Ravi